Those were developed, in part, as a byproduct of previous alliances in which
pharmaceutical companies payed for rights to develop would - be drugs discovered at Scripps, as well as through the more
traditional approach of licensing early - stage
compounds to startup companies that then raise money to develop them further.
Still, as involved as it is to blend the chemical
compounds of
traditional pharmaceutical products, creating any of a class of medications known as biologics is several orders of magnitude more difficult.